PEAK6
IBB icon

PEAK6’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158M Buy
830,100
+827,700
+34,488% +$142M 0.32% 61
2026
Q1 		$405K Sell
2,400
-200,500
-99% -$34.3M ﹤0.01% 2065
2025
Q4 		$34.2M Buy
202,900
+60,100
+42% +$9.76M 0.06% 243
2025
Q3 		$20.6M Buy
142,800
+100,000
+234% +$13.6M 0.03% 416
2025
Q2 		$5.41M Sell
42,800
-1,413,500
-97% -$174M 0.01% 913
2025
Q1 		$186M Sell
1,456,300
-199,200
-12% -$27M 0.42% 51
2024
Q4 		$219M Buy
+1,655,500
New +$233M 0.46% 42

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

PEAK6's IBB Position: Q2 2026 in Review

PEAK6 sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3 shares — an estimated $516 sold.

PEAK6 first reported a position in IBB in Q4 2024 and held it in 2 quarters. The position peaked at $983K in Q4 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • PEAK6 reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 3 iShares Biotechnology ETF shares in Q2 2026, an estimated $516.
  • PEAK6 first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 2 quarters.
  • PEAK6's iShares Biotechnology ETF position peaked at $983K in Q4 2024.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.